Sevoflurane downregulates IGF‑1 via microRNA‑98

Mol Med Rep. 2017 Apr;15(4):1863-1868. doi: 10.3892/mmr.2017.6219. Epub 2017 Feb 17.

Abstract

Insulin-like growth factor (IGF)-1 functions as a neuroprotective hormone and may protect against cognitive impairment, which may occur as a result of sevoflurane exposure. The aim of the present study was to assess the effect of sevoflurane on the production of IGF‑1 and investigate the molecular mechanisms underlying this regulation. The BRL rat hepatocyte cell line and adult mice were exposed to 1 or 2 minimal alveolar concentrations sevoflurane for 4 or 8 h. IGF‑1 and microRNA‑98 levels were quantified using an enzyme‑linked immunosorbent assay, western blotting and reverse transcription‑quantitative polymerase chain reaction analyses. The importance of microRNA‑98 in the regulation of IGF‑1 by sevoflurane was investigated using a microRNA‑98 inhibitor. Sevoflurane treatment reduced IGF‑1 levels and simultaneously upregulated microRNA‑98 expression levelsin rat hepatocytes and adult mice. Inhibition of microRNA‑98 attenuated this effect. Therefore, sevoflurane may reduce the synthesis of IGF‑1 by upregulating microRNA‑98 expression.

MeSH terms

  • Anesthetics, Inhalation / pharmacology*
  • Animals
  • Cell Line
  • Down-Regulation / drug effects*
  • Hepatocytes / drug effects
  • Hepatocytes / metabolism
  • Insulin-Like Growth Factor I / genetics*
  • Liver / drug effects*
  • Liver / metabolism
  • Methyl Ethers / pharmacology*
  • Mice
  • Mice, Inbred C57BL
  • MicroRNAs / genetics*
  • Rats
  • Sevoflurane
  • Up-Regulation / drug effects

Substances

  • Anesthetics, Inhalation
  • MIRN98 microRNA, mouse
  • MIRN98 microRNA-98, rat
  • Methyl Ethers
  • MicroRNAs
  • Sevoflurane
  • Insulin-Like Growth Factor I